FDA Head Califf Lays Out Biopharma Prioritization Gameplan

Recently appointed to his second term as the FDA’s commissioner, Dr. Robert Califf has been straightforward about his priorities for the agency and its mission in guiding public health solutions past the goal line. Now, Califf has called on the biopharma industry to laser focus on treatments for persistent population wellness issues such as chronic illness and addiction...